JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study

OBJECTIVES: With the recent global mpox outbreak, the JYNNEOS vaccine (Modified Vaccinia Ankara-Bavarian Nordic) was developed as a third-generation smallpox vaccine and initially favored for mpox immunization. Vaccine-associated side effects contribute to vaccine hesitancy. Consequently, tracking a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jaeeun, Kwon, Seunghyun Lewis, Park, Jinhee, Bae, Hyuna, Lee, Hyerim, Kwon, Geun-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korea Disease Control and Prevention Agency 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626317/
https://www.ncbi.nlm.nih.gov/pubmed/37920899
http://dx.doi.org/10.24171/j.phrp.2023.0182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626317/
https://www.ncbi.nlm.nih.gov/pubmed/37920899
http://dx.doi.org/10.24171/j.phrp.2023.0182

Ejemplares similares